VLP Biotech

Intellectual Property

The WHcAg VLP platform is protected by composition and methods patents held by the Vaccine Research Institute of San Diego and exclusively licensed to VLP Biotech, Inc. Additionally, VLP Biotech employs several proprietary technologies necessary to the efficient construction, screening and optimization of new WHcAg-VLP candidates.

Images courtesy of Princeton University & National Center for Biotechnology Information, U.S. National Library of Medicine.
© 2005-2008 VLP Biotech, Inc.